tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SUPN is currently covered by 3 analysts with an average price target of $66.23. This is a potential upside of $12.93 (24.26%) from yesterday's end of day stock price of $53.3.
Supernus Pharmaceuticals's activity chart (see below) currently has 101 price targets and 70 ratings on display. The stock rating distribution of SUPN is 60% HOLD and 40% BUY.
Analysts average stock forecasts to be materialized ratio is 78.7% with an average time for these price targets to be met of 342.44 days.
Highest price target for SUPN is $65, Lowest price target is $55, average price target is $61.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 19-Dec-2025. First documented stock forecast 12-Mar-2015.
Currently out of the existing stock ratings of SUPN, 6 are a HOLD (60%), 4 are a BUY (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Apr-2024
$55
$4.14 (8.14%)
$50
2 months 6 days ago
(19-Dec-2025)
8/10 (80%)
$3.52 (6.84%)
386
Buy Since 09-Oct-2025
$65
$14.14 (27.80%)
$40
4 months 16 days ago
(09-Oct-2025)
22/24 (91.67%)
$15.49 (31.29%)
337
Buy Since 29-Jul-2025
$63
$12.14 (23.87%)
$46
4 months 26 days ago
(30-Sep-2025)
5/6 (83.33%)
$15.21 (31.83%)
83
Buy Since 24-May-2021
$44
$-6.86 (-13.49%)
$40
4 years 2 months 24 days ago
(01-Dec-2021)
14/15 (93.33%)
$13.15 (42.63%)
461
Buy Since 10-May-2017
$35
$-15.86 (-31.18%)
$50
5 years 6 months 6 days ago
(19-Aug-2020)
4/4 (100%)
$11.6 (49.57%)
825
What is SUPN (Supernus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on SUPN (Supernus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most bullish on SUPN (Supernus Pharmaceuticals)?
Which analyst is the currently most reserved on SUPN (Supernus Pharmaceuticals)?
